Endoscopic therapies for patients with obesity: a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
Background: Obesity is a major threat to public health and traditional bariatric surgery continues to have low utilization. Endoscopic treatments for obesity have emerged that offer less risk, but questions remain regarding efficacy, durability, and safety. We compared the efficacy of endoscopic bariatric procedures as compared to other existing treatments. Methods: A literature search of Embase, Cochrane Central, and Pubmed was conducted from January 1, 2014 to December 7, 2021, including endoscopic bariatric therapies that were FDA or CE approved at the time of search to non-endoscopic treatments. Thirty-seven studies involving 15,639 patients were included. Primary outcomes included % total body weight loss (%TBWL), % excess body weight loss (%EBWL), and adverse events. Secondary outcomes included quality of life data and differences in hemoglobin A1C levels. Strength of clinical trial and observational data were graded according to the Cochrane methods. Results: Intragastric balloons achieved greater %TBWL with a range of 7.6–14.1% compared to 3.3–6.7% with lifestyle modification at 6 months, and 7.5–14.0% compared to 3.1–7.9%, respectively, at 12 months. When endoscopic sleeve gastroplasty (ESG) was compared to laparoscopic sleeve gastrectomy (LSG), ESG had less %TBWL at 4.7–14.4% compared to 18.8–26.5% after LSG at 6 months, and 4.5–18.6% as compared to 28.4–29.3%, respectively, at 12 months. For the AspireAssist, there was greater %TBWL with aspiration therapy compared to lifestyle modification at 12 months, 12.1–18.3% TBWL versus 3.5–5.9% TBWL, respectively. All endoscopic interventions had higher adverse events rates compared to lifestyle modification. Conclusion: This review is the first to evaluate various endoscopic bariatric therapies using only RCTs and observational studies for evaluation of weight loss compared with conservative management, lifestyle modification, and bariatric surgery. Endoscopic therapies result in greater weight loss compared to lifestyle modification, but not as much as bariatric surgery. Endoscopic therapies may be beneficial as an alternative to bariatric surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Techniques such as endoscopic sleeve gastroplasty, intragastric balloon placement, and duodenal-jejunal bypass liners (e.g., EndoBarrier) induce weight loss by reducing gastric volume or altering nutrient flow and absorption, achieving mean reductions of 10–15% over six to twelve months.100,101”
From Weight maintenance after discontinuation of GLP-1 therapies (2026) · cites this paper as [100]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Techniques such as endoscopic sleeve gastroplasty, intragastric balloon placement, and duodenal-jejunal bypass liners (e.g., EndoBarrier) induce weight loss by reducing gastric volume or altering nutrient flow and absorption, achieving mean reductions of 10–15% over six to twelve months.100,101”
From Weight maintenance after discontinuation of GLP-1 therapies (2026) · cites this paper as [100]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A systematic review of 37 trials involving 15,639 patients found that aspiration therapy resulted in a significantly higher TBWL (12.1–18.3%) compared to lifestyle modifications alone (3.5–5.9%) at 12 months [66].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“IGB therapy represents a short-term, minimally invasive intervention for weight loss in obese individuals, typically promoting a total body weight loss (TBWL) ranging from 7.5% to 14% [64,65,66,67].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [66]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Once-Weekly Semaglutide in Adults with Overweight or Obesity
Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2032183 · Cited by 5,205 · cited 1×
“This topic deserves further high-quality studies when determining the spectrum of management for patients with obesity [40].”
BackgroundThe Public Health Impact of Obesity
Visscher, T. L., & Seidell, J. C. (2001) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.22.1.355 · Cited by 1,008 · cited 1×
“with 9.2% diagnosed as severely obese [1, 2].”
InfluentialAbu Dayyeh, B. K., Kumar, N., Edmundowicz, S. A., Jonnalagadda, S., Larsen, M., Sullivan, S., Thompson, C. C., & Banerjee, S. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.03.1964 · Cited by 469
Ponce, J., Woodman, G., Swain, J., Wilson, E., English, W., Ikramuddin, S., Bour, E., Edmundowicz, S., Snyder, B., Soto, F., et al. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.006 · Cited by 279 · cited 1×
“Eleven studies were identified comparing IGB to lifestyle modification using %TBWL as the weight loss outcome [7–16] (Fig.”
MethodShort-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients
Alqahtani, A., Al-Darwish, A., Mahmoud, A. E., Alqahtani, Y. A., & Elahmedi, M. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.12.012 · Cited by 207
Thompson, C. C., Abu Dayyeh, B. K., Kushner, R., Sullivan, S., Schorr, A. B., Amaro, A., Apovian, C. M., Fullum, T., Zarrinpar, A., Jensen, M. D., et al. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.500 · Cited by 201 · cited 4×
“Both RCTs comparing AspireAssist to lifestyle modification demonstrated statistically significant increased %TBWL with aspiration therapy compared to lifestyle modification at 12 months, 12.1% and 18.3% TBWL versus 3.5% and 5.9% TBWL with mean differences of 8.8% and 12.4% [32, 33].”
BackgroundMethodResultInfluentialSullivan, S., Swain, J. M., Woodman, G., Antonetti, M., De La Cruz‐Muñoz, N., Jonnalagadda, S. S., Ujiki, M., Ikramuddin, S., Ponce, J., Ryou, M., et al. (2017) · Obesity · doi:10.1002/oby.21702 · Cited by 179 · cited 5×
“At 6 months, 2 studies compared %TBWL after ESG or POSE versus lifestyle modification [23, 24].”
BackgroundMethodInfluentialEndoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study
Fayad, L., Adam, A., Schweitzer, M., Cheskin, L. J., Ajayi, T., Dunlap, M., Badurdeen, D. S., Hill, C., Paranji, N., Lalezari, S., et al. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2018.08.030 · Cited by 175 · cited 1×
“Four studies compared total complication rates between ESG and LSG, of which 3 reported no significant difference and one noted higher rates following LSG (Lopez-Nava 0.04 [− 0.01, 0.1]) [25–27 , 29].”
ResultInfluentialIntragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial.
Courcoulas, A., Abu Dayyeh, B. K., Eaton, L., Robinson, J., Woodman, G., Fusco, M., Shayani, V, Billy, H., Pambianco, D., & Gostout, C. (2017) · International Journal of Obesity · doi:10.1038/ijo.2016.229 · Cited by 167 · cited 4×
“[8].”
BackgroundResultInfluential
Research works printed but not linked: 4
- Maggard-Gibbons M, Shekelle PG, Girgis MD et al (2022) Endoscopic bariatric interventions versus lifestyle interventions or surgery for weight loss in patients with obesity: a systematic review and meta-analysis. Washington (DC): Department of Veterans Affairs (US). https://www.ncbi.nlm.nih.gov/books/NBK587943/. Accessed Apr 2022
- Fuller N, Pearson S, Lau N et al (2010) A prospective, randomised, controlled trial of the BioEnterics® Intragastric Balloon (BIB) in the treatment of obese individuals with metabolic syndrome. Obes Rev 11:436438
- Abd El Mohsen M, Gostout CJ, Bakr A et al (2017) Laparoscopic greater curvature plication (LGCP) vs. endoscopic sleeve gastroplasty (ESG): similar efficacy with different physiology gastric plication. Obes Surg 27(1):630
- Sander BQ, Marchesini C, Paiva DS et al (2017) Intragastric balloon: a large brazilian multicentric study over 10,000 cases and 20 years of experience. United Eur Gastroenterol J 5(5):A618
Cited by
Lingvay, I., Cohen, R. V., Roux, C. W. L., & Sumithran, P. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01210-8 · Cited by 433
Female obesity: clinical and psychological assessment toward the best treatment
Guglielmi, V., Grave, R. D., Leonetti, F., & Solini, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1349794 · Cited by 44
Luca, M. D., Belluzzi, A., Salminen, P. T. P., Bueter, M., Pujol‐Rafols, J., Sakran, N., Stier, C. K., Taşkın, H. E., Chiappetta, S., Carrano, F. M., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13175106 · Cited by 17
“…this strategy is either on “bridge treatments” in patients affected by severe obesity or suboptimal outcomes after other nonsurgical approaches [32,33]; only in a few studies has endoscopic bariatric treatment been regarded as a “multimodal” approach for the treatment of obesity (i.e.,…”
BackgroundTasabehji, D., Saleh, S., & Mokadem, M. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124012 · Cited by 14
Ghusn, W., Divakar, A., Salameh, Y., Mosleh, K. A., & Storm, A. C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134681 · Cited by 9
“EBTs are minimally invasive endoluminal procedures designed to induce weight loss and improve metabolic parameters [18].”
Metadata
- Authors
- Weitzner, Z. N., Phan, J., Begashaw, M. M., Mak, S. S., Booth, M. S., Shekelle, P. G., Maggard-Gibbons, M., & Girgis, M. D.
- Affiliations
- University of California, Los Angeles (US)
- University of Southern California (US)
- Veterans Health Administration (US)
- RAND Corporation (US)
- Corresponding author
- Girgis, Mark D.
- ORCID
- Venue
- Surgical Endoscopy
- Published
- 2023-09-20
- Volume
- 37
- Issue
- 11
- Pages
- 8166-8177
- ISSN
- 0930-2794 (ISSN-L)
- 1432-2218
- PMC
- PMC10615978
- OpenAlex
- W4386881978
- Cited by
- 27
- References
- 34
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 8 · 2023: 1
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Surgical Endoscopy (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Surgery › Minimally Invasive Surgical Techniques
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Keywords
- obesity, endoscopic bariatric therapy, intragastric balloon, endoscopic sleeve gastroplasty, laparoscopic sleeve gastrectomy, aspiration therapy, weight loss, excess weight loss, lifestyle modification, adverse events, HbA1c, quality of life
- MeSH terms
- Endoscopy, Humans, Obesity, Obesity, Morbid, Quality of Life, Gastroplasty, Weight Loss, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endoscopic therapies for patients with obesity: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1007/s00464-023-10390-6
- The paper
- Weitzner, Z. N., Phan, J., Begashaw, M. M., Mak, S. S., Booth, M. S., Shekelle, P. G., Maggard-Gibbons, M., & Girgis, M. D. (2023). Endoscopic therapies for patients with obesity: a systematic review and meta-analysis. Surgical Endoscopy. https://doi.org/10.1007/s00464-023-10390-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.